It is primarily prescribed when obesity is causing serious health problems and other weight loss strategies have failed
Increased Caloric Burn : It can slightly increase energy expenditure, which supports weight loss efforts
The same principles that guide semaglutide dosing escalation apply regardless of delivery format
For the all semaglutide OW cohort, eligible adults (aged 18 years) with 1 diagnosis on a confirmatory medical claim for T2D (any time prior to and including the index date) who initiated semaglutide OW with 2 filled prescription claims were identified, with the first claim during the selection window of January 1, 2018 to February 28, 2022, and the second claim during the follow-up period (1-year period after the index date)
Further experimental exploration, clinical trials, case-control studies, and cohort studies are needed to validate the results